| HGNC Family | Homeoboxes |
| Name | pre-B-cell leukemia homeobox 3 |
| Description | Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including eye development; nervous system development; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including adult locomotory behavior; dorsal spinal cord development; and regulation of respiratory gaseous exchange by nervous system process. Predicted to be located in chromatin. Predicted to be part of transcription regulator complex. Predicted to be active in nucleus. Biomarker of esophagus squamous cell carcinoma. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nIn hematologic malignancies, PBX3 plays a central role as part of a homeobox gene signature that is associated with adverse outcomes. In cytogenetically abnormal acute myeloid leukemia, down‐regulation of miR‐181 family members leads to up‐regulation of PBX3 (with HOXA7/HOXA9/HOXA11), correlating with poor survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In MLL‐rearranged AML, PBX3 is consistently coexpressed with HOXA9 and functions as a critical cofactor for HOXA9–mediated leukemic transformation; its depletion dramatically impairs MLL‐fusion–driven cell transformation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Moreover, co‐expression of PBX3 with MEIS1 is sufficient to induce AML in experimental models"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ", while epigenetic aberrations in leukemic stem cells yield high PBX3 levels that are essential for leukemia maintenance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " A four‐gene HOXA/TALE signature that includes PBX3 predicts adverse outcome in cytogenetically normal AML and appears to contribute to chemoresistance"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", and in NPM1‐mutated AML, PBX3 up‐regulation—partially via DOT1L–mediated H3K79 hypermethylation—is critical for leukemic cell survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn a diverse range of solid tumors, PBX3 overexpression promotes malignant phenotypes by enhancing proliferation, migration, invasion, and the epithelial–mesenchymal transition. In hepatocellular carcinoma (HCC), PBX3 is necessary and sufficient for the acquisition and maintenance of tumor‐initiating properties, with several microRNAs (eg, miR‐33a‐3p and miR‐302a) shown to directly target PBX3 and thereby suppress tumor progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": " In colorectal cancer, PBX3 contributes to a full EMT phenotype and its expression—as regulated by WNT activation and EMT transcription factors—is linked to metastasis and poor survival."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "13"}]}, {"type": "t", "text": " In prostate cancer, androgen regulation of PBX3 and its unusual shift from nuclear to cytosolic localization together have prognostic implications."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " In gastric cancer, PBX3 is commonly overexpressed where it drives EMT, with repression by miR‐144‑3p limiting cell proliferation and invasion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "18"}]}, {"type": "t", "text": " Similar oncogenic roles have been elucidated in pilocytic astrocytoma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": ", multiple myeloma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": ", and glioma where PBX3 sustains cell cycle progression and tumor growth."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "23"}]}, {"type": "t", "text": " In addition, in pancreatic and papillary thyroid carcinomas, PBX3 fosters proliferation, migration, and angiogenesis"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "26"}]}, {"type": "t", "text": ", while in melanoma, competitive regulation by miR‑4458 and HuR modulates PBX3 levels to impact cell growth and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": " Furthermore, in breast cancer, stabilization of PBX3 via USP14‐mediated deubiquitination downstream of ATRAP contributes to enhanced tumor aggressiveness"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": ", and in cervical and bladder cancers, PBX3 is similarly targeted by tumor‐suppressive miRNAs or modulated through competing endogenous RNAs to regulate EMT and cell survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its direct oncogenic functions, PBX3 is subject to diverse regulatory and epigenetic modifications that bear prognostic and therapeutic significance. Aberrant promoter methylation of PBX3 in peripheral blood leukocytes has been explored as a prognostic marker in colorectal and gastric cancers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": " In sepsis, the 3′‐UTR of PBX3 acts as a competing endogenous RNA to modulate HMGB1 expression and thereby elicit inflammatory responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": " Similarly, in the context of preeclampsia, noncoding RNAs—including miR‑655‑3p and circRNAs—regulate PBX3 in trophoblasts, affecting cell invasion and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": " Finally, genetic studies evaluating PBX3 polymorphisms in congenital heart defects and celiac disease have underscored its potential role as a modifier gene, although not all associations reach significance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Zejuan Li, Hao Huang, Yuanyuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2011-10-386235"}], "href": "https://doi.org/10.1182/blood-2011-10-386235"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22251480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22251480"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zejuan Li, Zhiyu Zhang, Yuanyuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 is an important cofactor of HOXA9 in leukemogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-07-442004"}], "href": "https://doi.org/10.1182/blood-2012-07-442004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23264595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23264595"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zejuan Li, Ping Chen, Rui Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-15-1566"}], "href": "https://doi.org/10.1158/0008-5472.CAN-15-1566"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26747896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26747896"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Huidong Guo, Yajing Chu, Le Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.30739"}], "href": "https://doi.org/10.1002/ijc.30739"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28411381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28411381"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Glenda J Dickson, Fabio G Liberante, Laura M Kettyle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Haematologica (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3324/haematol.2012.079012"}], "href": "https://doi.org/10.3324/haematol.2012.079012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23539541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23539541"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wu Zhang, Chen Zhao, Junmei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.26900"}], "href": "https://doi.org/10.7150/thno.26900"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30214626"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30214626"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Haibo Han, Yantao Du, Wei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms9271"}], "href": "https://doi.org/10.1038/ncomms9271"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26420065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26420065"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shu-Yan Han, Hai-Bo Han, Xiu-Yun Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9886"}], "href": "https://doi.org/10.18632/oncotarget.9886"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27285759"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27285759"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Meng Wang, Guoyue Lv, Chao Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-38435-0"}], "href": "https://doi.org/10.1038/s41598-018-38435-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30765768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30765768"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hai-Bo Han, Jin Gu, Deng-Bo Ji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v20.i48.18260"}], "href": "https://doi.org/10.3748/wjg.v20.i48.18260"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25561793"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25561793"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Sebastian Lamprecht, Markus Kaller, Eva Marina Schmidt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-2572"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-2572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29391352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29391352"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Wen-Fang Li, Arin Herkilini, Yu Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Pharmacol Sin (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41401-020-00599-9"}], "href": "https://doi.org/10.1038/s41401-020-00599-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33526870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33526870"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Hongru Sun, Hao Huang, Dapeng Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.2321"}], "href": "https://doi.org/10.1002/cam4.2321"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31140752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31140752"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Håkon Ramberg, Ayham Alshbib, Viktor Berge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of PBX3 expression by androgen and Let-7d in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-10-50"}], "href": "https://doi.org/10.1186/1476-4598-10-50"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21548940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21548940"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Håkon Ramberg, Helene Hartvedt Grytli, Ståle Nygård, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 is a putative biomarker of aggressive prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.30220"}], "href": "https://doi.org/10.1002/ijc.30220"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27273830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27273830"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Butian Li, Shengping Zhang, Hao Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.01.084"}], "href": "https://doi.org/10.1016/j.bbrc.2017.01.084"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28111340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28111340"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yanke Li, Zhe Sun, Zhi Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 is overexpressed in gastric cancer and regulates cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-013-1573-6"}], "href": "https://doi.org/10.1007/s13277-013-1573-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24375258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24375258"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xiaomei Zheng, Hongwei Xiao, Xiaoxiao Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal circKIAA1797 Regulates Cell Progression and Glycolysis by Targeting miR-4429/PBX3 Pathway in Gastric Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Genet (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10528-023-10529-z"}], "href": "https://doi.org/10.1007/s10528-023-10529-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37730964"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37730964"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Cheng-Ying Ho, Eli Bar, Caterina Giannini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuro Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/neuonc/nos269"}], "href": "https://doi.org/10.1093/neuonc/nos269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23161775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23161775"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yinghao Lu, Depei Wu, Jishi Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2016.04.069"}], "href": "https://doi.org/10.1016/j.bbrc.2016.04.069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27086852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27086852"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Xiupeng Xu, Ning Cai, Zhongyuan Bao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-017-2603-9"}], "href": "https://doi.org/10.1007/s11060-017-2603-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28856521"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28856521"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Qi Wang, Zhong-Wei Zhuang, Yi-Ming Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IUBMB Life (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iub.1943"}], "href": "https://doi.org/10.1002/iub.1943"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30290058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30290058"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Cuicui Pan, Xueli Bai, Na Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0293647"}], "href": "https://doi.org/10.1371/journal.pone.0293647"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38324550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38324550"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Zhisheng Qiu, Xiaochun Wang, Yuping Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Biophys Sin (Shanghai) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/abbs/gmz096"}], "href": "https://doi.org/10.1093/abbs/gmz096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31518383"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31518383"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Xing Huang, Zihe Wang, Shengzhong Hou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.2016326"}], "href": "https://doi.org/10.1080/21655979.2021.2016326"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35142595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35142595"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Qin Chen, Wen-Ying Yu, Huan-Huan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 Promotes Tumor Growth and Angiogenesis via Activation of AT1R/VEGFR2 Pathway in Papillary Thyroid Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/8954513"}], "href": "https://doi.org/10.1155/2020/8954513"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32047817"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32047817"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Henghua Zhou, Yamin Rao, Qilin Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-4458/human antigen R (HuR) modulates PBX3 mRNA stability in melanoma tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Dermatol Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00403-020-02051-8"}], "href": "https://doi.org/10.1007/s00403-020-02051-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32157373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32157373"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Dandan Wang, Xiaoying Jin, Mengxia Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "USF1-ATRAP-PBX3 Axis Promote Breast Cancer Glycolysis and Malignant Phenotype by Activating AKT/mTOR Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.69134"}], "href": "https://doi.org/10.7150/ijbs.69134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35414770"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35414770"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Hongfang Li, Jing Wang, Feixue Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Future Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/fon-2018-0575"}], "href": "https://doi.org/10.2217/fon-2018-0575"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30859853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30859853"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Zongyu Xia, Qin Wang, Peng Lu "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA LINC00885 promotes bladder cancer progression by targeting the miR-98-5p/PBX3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Biol (Noisy-le-grand) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14715/cmb/2023.69.3.24"}], "href": "https://doi.org/10.14715/cmb/2023.69.3.24"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37300672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37300672"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Hana Hájková, Markus Hsi-Yang Fritz, Cedrik Haškovec, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13045-014-0066-4"}], "href": "https://doi.org/10.1186/s13045-014-0066-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25266220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25266220"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Wenzhen Xie, Haibo Zhou, Qian Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-020-03171-4"}], "href": "https://doi.org/10.1007/s00432-020-03171-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32144534"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32144534"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Yunzhong Zhang, Jing Feng, Jizhen Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pre-B cell leukemia transcription factor 3 induces inflammatory responses in human umbilical vein endothelial cells and murine sepsis via acting a competing endogenous RNA for high mobility group box 1 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.8609"}], "href": "https://doi.org/10.3892/mmr.2018.8609"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29484406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29484406"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "H Song, X Wang, J-C Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-655-3p inhibits growth and invasiveness of trophoblasts via targeting PBX3 and thus deteriorates preeclampsia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202010_23383"}], "href": "https://doi.org/10.26355/eurrev_202010_23383"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33155190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33155190"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Qinghua Mao, Hong Zou "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0032962 promotes trophoblast cell progression as ceRNA to target PBX3 via sponging miR-326 in preeclampsia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.repbio.2021.100571"}], "href": "https://doi.org/10.1016/j.repbio.2021.100571"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34742151"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34742151"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Cammon B Arrington, Benjamin R Dowse, Steven B Bleyl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Non-synonymous variants in pre-B cell leukemia homeobox (PBX) genes are associated with congenital heart defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Med Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejmg.2012.02.002"}], "href": "https://doi.org/10.1016/j.ejmg.2012.02.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22426282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22426282"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "B Dema, A Martínez, M Fernández-Arquero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lack of replication of celiac disease risk variants reported in a Spanish population using an independent Spanish sample."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Immun (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/gene.2009.54"}], "href": "https://doi.org/10.1038/gene.2009.54"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19626039"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19626039"}]}]}]}
|
| Proteins | PBX3_HUMAN |
| NCBI Gene ID | 5090 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PBX3 has 11,135 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 122 datasets.
Click the + buttons to view associations for PBX3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PBX3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PBX3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PBX3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PBX3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PBX3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PBX3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PBX3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PBX3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PBX3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PBX3 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PBX3 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PBX3 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PBX3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PBX3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of PBX3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing PBX3 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PBX3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PBX3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PBX3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PBX3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PBX3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PBX3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PBX3 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PBX3 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PBX3 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PBX3 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PBX3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with PBX3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PBX3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PBX3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PBX3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PBX3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PBX3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PBX3 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PBX3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PBX3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PBX3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PBX3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PBX3 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PBX3 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PBX3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PBX3 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PBX3 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PBX3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PBX3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PBX3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PBX3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PBX3 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PBX3 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PBX3 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PBX3 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PBX3 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PBX3 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PBX3 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PBX3 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PBX3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PBX3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PBX3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PBX3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PBX3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PBX3 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PBX3 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PBX3 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PBX3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with PBX3 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with PBX3 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with PBX3 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PBX3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PBX3 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PBX3 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PBX3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PBX3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PBX3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving PBX3 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PBX3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PBX3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PBX3 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PBX3 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PBX3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PBX3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PBX3 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing PBX3 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PBX3 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PBX3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PBX3 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PBX3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PBX3 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PBX3 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PBX3 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PBX3 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PBX3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PBX3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PBX3 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PBX3 protein from the Wikipathways PFOCR 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PBX3 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PBX3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PBX3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PBX3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of PBX3 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PBX3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PBX3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PBX3 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PBX3 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PBX3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PBX3 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PBX3 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PBX3 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PBX3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PBX3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PBX3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PBX3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PBX3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PBX3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PBX3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PBX3 protein from the WikiPathways Pathways 2024 dataset. | |